Cencora, Inc. (COR)
NYSE
Key stats Fiscal year 2025
Income statement
- Revenue
- 321,332,819,000 9.3%
- Net income
- 1,554,169,000 3%
- Gross profit
- 11,478,539,000
- Operating income
- 2,628,601,000
- Earnings per share
- 8.02 5.5%
Growth and profitability
- Gross margin
- 3.57
- Operating margin
- 0.82
- Net margin
- 0.48
- Return on equity
- 103.06
- Return on assets
- 2.03
- Free cash flow margin
- 1.00
Balance sheet
- Total assets
- 76,590,112,000
- Shareholders' equity
- 1,508,019,000
- Cash and equivalents
- 4,356,138,000
- Debt
- 7,660,773,000
- Net debt
- 3,304,635,000
- Current ratio
- 0.90
- Debt to equity
- 5.08
Cash flow and ratios
- Operating cash flow
- 3,875,120,000
- Free cash flow
- 3,207,139,000
Shareholder returns
- Dividend per share
- 2.20
- Dividends paid
- 437,081,000
- Share buybacks
- 435,471,000
- Shares outstanding
- 190,827,165
- Book value per share
- 7.90
Company information
- Headquarters
- Conshohocken, PA
- Exchange
- NYSE
- Fiscal year end
- 09-30
- Industry (SEC)
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
Fiscal year end: · Source: SEC EDGAR
Cencora, Inc. trades on NYSE under the ticker symbol COR. This page brings together its price chart, company profile, key financial figures and technical indicators.